Investigational drug · Phase 2
Fluzone Qudrivalent
Not approved by FDA. In 2 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Healthy Volunteers, Influenza Immunization, Influenza.
Phase 2Last checked: Nov 20, 2026Latest source record: Aug 4, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
2
0 still active
All registered trials
4
Any phase or sponsor naming "Fluzone Qudrivalent"
First trial start
2024
Apr 1, 2024
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "Fluzone Qudrivalent", any sponsor or status.
Conditions studied
As listed on its trial records.
- Healthy Volunteers
- Influenza Immunization
- Influenza
Approved drugs for the same conditions: Influenza · Infectious disease and vaccines
Largest trials
Live from ClinicalTrials.gov: studies naming "Fluzone Qudrivalent" as an intervention, largest first.
- A Study on the Safety and Immunogenicity of Hexavalent Influenza mRNA Vaccine in Adult Participants 50 Years of Age and OlderPivotal-lookingCompleted
Sanofi Pasteur, a Sanofi CompanySanofi (SNY)
NCT06744205 · 1,162 participants · Start Jan 6, 2025 · Primary completion May 22, 2026
Drug: Trivalent (TIV) messenger ribonucleic acid (mRNA) hemagglutinin (HA) Vaccine 1; TIV mRNA-neuraminidase (NA) and 3 more · For: Influenza; Healthy Volunteers
Sites: Birmingham, Alabama; Mobile, Alabama; Tempe, Arizona · 24 sites in all
- A Study to Investigate the Safety and Immunogenicity of the Quadrivalent Influenza mRNA Vaccines in Adults Aged 18 Years and AbovePivotal-lookingCompleted
Sanofi Pasteur, a Sanofi CompanySanofi (SNY)
NCT06361875 · 908 participants · Start Apr 1, 2024 · Primary completion Jun 9, 2025
Drug: Quadrivalent Influenza mRNA Vaccine MRT5421; Quadrivalent Influenza mRNA Vaccine MRT5424 and 4 more · For: Influenza Immunization; Healthy Volunteers
Sites: San Diego, California; Hialeah, Florida; Hollywood, Florida · 13 sites in all
- Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5413 in Adult Participants18 Years of Age and OlderPivotal-lookingCompleted
Sanofi Pasteur, a Sanofi CompanySanofi (SNY)
NCT05650554 · 682 participants · Start Dec 12, 2022 · Primary completion Apr 2, 2024
Drug: Quadrivalent Influenza mRNA Vaccine MRT5413; Quadrivalent Recombinant Influenza Vaccine and 2 more · For: Influenza Immunization
Sites: Chula Vista, California; Gardena, California; Long Beach, California · 35 sites in all
- Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5407 in Adult Participants18 Years of Age and OlderPivotal-lookingCompleted
Sanofi Pasteur, a Sanofi CompanySanofi (SNY)
NCT05553301 · 560 participants · Start Oct 3, 2022 · Primary completion Jan 19, 2024
Drug: Quadrivalent Influenza mRNA Vaccine MRT5407; Quadrivalent Recombinant Influenza Vaccine and 2 more · For: Influenza Immunization
Sites: Rolling Hills Estates, California; San Diego, California; DeLand, Florida · 25 sites in all
Newest research
PubMed records naming it or its code names, newest first.
No PubMed records name it yet, which is common for early code-named drugs.
Also in development for Healthy Volunteers
- PPV2323-valent Pneumococcal Polysaccharide Vaccine, lot 1Phase 36 trials
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd · Healthy Volunteers, Streptococcus Pneumoniae Infection, Pneumococcal Disease
- PCV21 vaccinePhase 35 trials
Sanofi · Pneumococcal Immunization, Healthy Volunteers
- TDVTAK-003, Tetravalent Dengue VaccinePhase 35 trials
Takeda · Dengue Fever, Healthy Volunteers
- DTap-HepB-IPV-Hib vaccineHexyon, Infanrix hexaPhase 34 trials
Sanofi · Healthy Volunteers, Meningococcal Immunization, Pneumococcal Immunization
- MenACYW conjugate vaccineNimenrixPhase 34 trials
Sanofi · Healthy Volunteers, Meningococcal Immunisation, Meningococcal Immunization
- poliomyelitis vaccinePhase 33 trials
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd · Healthy Volunteers, Whooping Cough, Diphtheria
- HexaximHexaxim Vaccine, DTaP-IPV-Hib-HepB vaccinePhase 32 trials
Sanofi · Pneumococcal Immunization, Meningococcal Immunisation, Healthy Volunteers
- IIV-HDstandalonePhase 32 trials
Sanofi · COVID-19 Immunization, Influenza Immunization, Immunization
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do. More from Sanofi.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.